# Healthcare AI Investors and Venture Capital Firms Directory

> **Executive Summary**: This comprehensive directory provides detailed information on healthcare AI investors, venture capital firms, angel investors, accelerators, and pitch competitions relevant to healthcare technology startups. The research covers both the Dallas-Fort Worth (DFW) metropolitan area, which has emerged as a significant healthcare innovation hub with approximately $1.2 billion in healthcare funding in 2025, and national investors who are actively shaping the healthcare AI landscape. The directory includes investment focus areas, typical check sizes, contact information, and portfolio examples to help healthcare entrepreneurs identify and approach appropriate funding sources. Key findings indicate that DFW's healthcare ecosystem benefits from strong corporate presence and growing venture activity, while national healthcare AI investment has reached unprecedented levels with $10.5 billion in VC funding in 2024 and healthcare AI spending hitting $1.4 billion in 2025.

---

## Part I: Dallas-Fort Worth Metropolitan Area Healthcare AI Investors

The Dallas-Fort Worth metropolitan area has established itself as one of the fastest-growing healthcare innovation hubs in the United States. In 2025, DFW startups raised approximately $4.8 billion across 320+ deals, with healthcare and health technology commanding $1.2 billion of that total—the largest sector by far [1]. The region's ecosystem is supported by over 30 Fortune 1000 companies, providing healthcare startups with access to enterprise customers, seasoned executives, and strategic partnerships. The following sections detail the venture capital firms, angel networks, and investment organizations actively investing in healthcare AI and medical technology companies within the DFW metropolitan area.

### 1.1 DFW-Based Venture Capital Firms

#### Scientific Health Development (SHD Partners)

Scientific Health Development, operating as SHD Partners, is a boutique venture capital firm headquartered in Dallas, Texas, that specializes exclusively in early-stage medtech investments [2]. The firm was co-founded by Philip Romano and Stuart Fitts, with Andrew Offer joining as a key figure in 2007. SHD Partners distinguishes itself by focusing on innovative medical technologies that address unmet clinical needs while requiring smaller amounts of funding compared to traditional venture-backed approaches. Their investment philosophy centers on easily adoptable technologies that improve patient outcomes while minimizing overall economic burden on the healthcare system.

The firm's investment criteria emphasize companies with attainable, near-term value inflection points that could lead to successful exit outcomes. SHD Partners specifically targets U.S.-based early-stage medtech companies that demonstrate clear clinical utility and commercial potential. Their portfolio includes companies across various medical technology subsectors, though specific portfolio company names are maintained on their dedicated portfolio page. The firm maintains a contact page for prospective portfolio companies and welcomes inquiries from healthcare entrepreneurs developing innovative medical technologies. SHD Partners' Dallas location positions them well to serve the growing DFW medtech ecosystem while maintaining national investment scope.

**Contact Information:**
- **Website:** shdpartners.com
- **Contact Page:** shdpartners.com/contact/
- **Location:** Dallas, TX

#### Sentiero Ventures

Sentiero Ventures is a Dallas-based venture capital fund that invests in early-stage startups developing artificial intelligence-enabled SaaS solutions [3]. While not exclusively healthcare-focused, the firm has significant interest in applied AI for enterprise and B2B use cases, including healthcare applications. Their investment stage focus spans pre-seed to seed rounds, making them particularly attractive for healthcare AI companies at the earliest stages of commercialization. Sentiero Ventures actively backs startups using AI to reshape business operations across multiple sectors, offering domain expertise and early capital to AI founders navigating the complex healthcare landscape.

The firm's portfolio includes companies such as DocQ, OutDefine, and Acclinate, demonstrating their commitment to technology-driven solutions that can scale efficiently. Sentiero Ventures provides more than capital; they offer strategic guidance derived from deep understanding of AI implementation challenges and enterprise sales cycles. For healthcare AI startups seeking seed funding with investors who understand the nuances of AI technology adoption in regulated industries, Sentiero Ventures represents a compelling option within the DFW investment community.

**Contact Information:**
- **Website:** sentiero.vc
- **Location:** Dallas, TX
- **Stage:** Pre-seed to Seed

#### Green Park & Golf Ventures

Green Park & Golf Ventures is a Dallas-based venture capital firm that bridges healthcare innovation with enterprise technology investment [3]. Their investment focus encompasses healthcare, life sciences, and data-driven enterprise software, positioning them uniquely to understand the intersection of clinical needs and technological solutions. The firm targets seed to Series A investments and has built a portfolio that includes Lantern Pharma, OncoLens, and BioIQ—companies at the forefront of digitizing healthcare delivery and operations.

The firm's investment thesis centers on founders who are actively transforming healthcare through technology, with particular interest in companies that can demonstrate clear paths to market adoption and revenue generation. Green Park & Golf Ventures brings operational experience and enterprise relationships that extend beyond capital provision, offering portfolio companies strategic value in navigating complex healthcare markets. Their Dallas headquarters provides geographic proximity to major healthcare systems and payers in the DFW region, enabling meaningful engagement with the local healthcare ecosystem.

**Contact Information:**
- **Website:** gpgventures.com
- **Location:** Dallas, TX
- **Stage:** Seed to Series A
- **Focus Areas:** Healthcare, life sciences, data-driven enterprise software

#### Dallas Venture Capital (DVC)

Dallas Venture Capital is headquartered in Irving, Texas, within the DFW metropolitan area, and operates with a focus on bridging U.S. and India innovation markets [3]. While their primary focus is on B2B SaaS, AI, and data infrastructure companies, they have demonstrated interest in healthcare technology companies that fit their investment thesis. DVC invests from seed through Series B stages, providing growth capital for companies scaling their operations and market presence.

The firm offers the DVC Advantage program, which provides portfolio companies with customer introductions, go-to-market playbooks, and growth mentorship. Their portfolio includes companies such as Kore.ai, Yellow.ai, and IntelliDoctor, demonstrating their appetite for AI-driven solutions. For healthcare AI companies with ambitions for international expansion, particularly into Indian markets, DVC offers unique strategic value through their cross-border network and operational support. The firm's stage flexibility makes them suitable for healthcare AI companies at various growth phases seeking to accelerate their development trajectory.

**Contact Information:**
- **Website:** dallasvc.com
- **Location:** Irving, TX (DFW Metroplex)
- **Stage:** Seed to Series B
- **Focus Areas:** B2B SaaS, AI, data infrastructure

#### Perot Jain

Perot Jain is a Dallas-based venture capital firm that invests in seed to Series A companies across logistics, healthcare, and advanced manufacturing sectors [3]. The firm's investment approach combines enterprise relationships with operational experience, providing portfolio companies with strategic guidance and market access. Their healthcare investments reflect a focus on companies building real-world infrastructure that addresses systemic healthcare challenges.

The firm's portfolio includes companies such as AEye, Hypergiant, and ParkHub, demonstrating their willingness to invest in technically ambitious companies across multiple sectors. Perot Jain's healthcare-related investments are characterized by a preference for companies with clear paths to market adoption and the ability to scale operations efficiently. The firm's Dallas base provides access to the extensive healthcare systems and corporate partners throughout the DFW region, enabling meaningful strategic partnerships for portfolio companies. For healthcare AI companies seeking investors with operational expertise and strong corporate relationships, Perot Jain represents a differentiated option within the local investment community.

**Contact Information:**
- **Website:** perotjain.com
- **Location:** Dallas, TX
- **Stage:** Seed to Series A
- **Focus Areas:** Logistics, healthcare, advanced manufacturing

#### S3 Ventures

S3 Ventures is headquartered in Austin, Texas, but is an active participant in Dallas-Fort Worth deal flow and represents one of Texas's largest venture capital firms [3]. The firm invests from seed through growth stages, with focus areas spanning SaaS, medtech, and frontier technology. Their portfolio includes companies such as Alkami, Mavenir, and WP Engine, demonstrating their capacity to back category-leading companies across technology and healthcare sectors.

The firm's healthcare investments, while not exclusively AI-focused, include medtech companies that leverage technology to improve patient outcomes and healthcare delivery efficiency. S3 Ventures' Texas presence and regional reputation make them a natural partner for DFW healthcare companies seeking growth capital with local investors who understand the Texas market dynamics. Their long-term partnership approach with founders aligns well with the development timelines typical of healthcare AI companies requiring extended runway for clinical validation and regulatory processes.

**Contact Information:**
- **Website:** s3vc.com
- **Location:** Austin, TX (active in DFW)
- **Stage:** Seed to Growth
- **Focus Areas:** SaaS, medtech, frontier technology

### 1.2 DFW-Based Private Equity and Investment Funds

#### AI Healthcare Capital

AI Healthcare Capital is a growth-stage private equity fund headquartered in The Woodlands, Texas, with a focused mission of revolutionizing the healthcare system through strategic investments in Healthcare Technology [4]. While not physically located in DFW, the firm's Texas base and healthcare AI focus make them a relevant investor for DFW-based healthcare AI companies seeking growth capital. The fund's vision centers on protecting and improving lives for both patients and healthcare professionals by addressing critical gaps in access, diagnostics, and follow-up care.

The fund's investment focus spans five primary areas: AI-Powered Virtual Symptom Assessment and Care Navigation, AI-Assisted Patient Visits and Patient Care Automation, AI-Enhanced Post-Visit Care and Patient Support, AI-Driven Patient Transitions and Workflow Automation, and AI-Driven Remote Patient Care Monitoring and Guidance. This comprehensive focus on AI applications throughout the care continuum demonstrates the fund's deep understanding of healthcare AI opportunities and challenges. AI Healthcare Capital is led by Managing Partner and Founder Ewelina Wołoszyn, who brings expertise in healthcare technology investment and operational leadership.

The fund maintains an Executive Management team and Advisory Council, providing portfolio companies with strategic guidance and operational support. AI Healthcare Capital's affiliation with global organizations such as ASTIA - Global Investment Organization suggests a broad network that can benefit healthcare AI companies with ambitions beyond regional markets. For DFW healthcare AI companies seeking growth-stage private equity investment with specific healthcare AI expertise, AI Healthcare Capital represents a compelling option.

**Contact Information:**
- **Address:** 2001 Timberloch Place, Suite 500, The Woodlands, Texas, 77380
- **Website:** aihealthcarecapital.com
- **Focus:** Healthcare Technology AI, growth-stage private equity

#### Lakewood Healthcare Capital

Lakewood Healthcare Capital is a Dallas-based healthcare-focused private equity firm that invests in and partners with healthcare organizations across all segments of the healthcare industry [5]. The firm's investment approach encompasses providers, service organizations, and healthcare technology companies, providing diversified opportunities for healthcare AI companies at various stages of development. While the firm's website was under construction at the time of research, their confirmed presence in the Dallas healthcare investment community and broad healthcare focus positions them as a potential investor for healthcare AI companies seeking growth capital.

The firm's comprehensive approach to healthcare investment, covering providers, services, and technology, suggests flexibility in investment structures and company stages. For DFW healthcare AI companies seeking investors with deep healthcare industry expertise and the capacity to provide growth capital beyond traditional venture rounds, Lakewood Healthcare Capital merits consideration despite limited publicly available detailed information at this time.

**Contact Information:**
- **Website:** lakewoodhc.com
- **Location:** Dallas, TX
- **Focus:** Healthcare providers, service organizations, healthcare technology

### 1.3 DFW Angel Networks and Individual Investors

#### North Texas Angel Network

The North Texas Angel Network is the largest angel network in the Dallas Metroplex, comprising approximately 70 members who collectively invest in 10 to 15 dynamic startups annually [6]. While not exclusively focused on healthcare, the network's DFW presence and investment activity make them a relevant funding source for healthcare AI companies at early stages. The network coordinates syndicated pre-seed and seed investments, enabling individual angels to participate in larger rounds than they might pursue independently.

Individual angel checks within the North Texas Angel Network typically range from $25,000 to $250,000 per investor, with syndicate rounds aggregating $250,000 to $750,000 in total investment. This capital structure is well-suited for healthcare AI companies at the prototype or early revenue stages that need funding to advance product development and initiate market engagement. The network's membership includes seasoned executives from various industries, providing portfolio companies with operational guidance and industry connections beyond capital provision.

**Contact Information:**
- **Website:** northtexasangels.org
- **Location:** Dallas Metroplex
- **Angel Members:** Approximately 70
- **Annual Investments:** 10-15 startups
- **Typical Syndicate Size:** $250,000-$750,000

#### Cowtown Angels

Cowtown Angels is Fort Worth's leading angel investor network, connecting entrepreneurs with investors to accelerate growth and reward strategic risk-taking [7]. Named after Fort Worth's historical nickname, the network serves the western portion of the DFW metropolitan area and provides healthcare entrepreneurs with access to local angel capital. The organization's focus on connecting entrepreneurs with investors aligns with the needs of healthcare AI companies seeking early-stage funding from investors who understand the local market dynamics.

Cowtown Angels' emphasis on strategic risk-taking suggests openness to healthcare AI companies whose business models may deviate from traditional approaches or require extended development timelines typical of healthcare innovation. For healthcare AI entrepreneurs based in Fort Worth or the western DFW region, Cowtown Angels provides a localized funding option with investors who understand the specific opportunities and challenges of building healthcare technology companies in North Texas.

**Contact Information:**
- **Website:** cowtownangels.org
- **Location:** Fort Worth, TX
- **Focus:** Connecting entrepreneurs with angel investors

#### Angel Physicians Fund

Angel Physicians Fund is a healthcare-focused investment organization that partners closely with entrepreneurs and innovators who are dedicated to unlocking new opportunities in healthcare [8]. The fund's physician investor base provides healthcare AI companies with access to clinical expertise and healthcare industry insights that extend beyond traditional financial investor capabilities. This clinical perspective is particularly valuable for healthcare AI companies developing solutions that require clinical validation, payer acceptance, or provider adoption.

The fund's partnership approach suggests involvement that goes beyond capital provision, potentially including strategic guidance on clinical development, regulatory pathways, and market access strategies. For healthcare AI companies seeking investors who can provide both capital and clinical domain expertise, Angel Physicians Fund represents a differentiated investment source within the DFW healthcare investment ecosystem.

**Contact Information:**
- **Website:** angelphysicians.com
- **Focus:** Healthcare entrepreneurs and innovators

### 1.4 DFW Healthcare Accelerators and Incubators

#### Health Wildcatters

Health Wildcatters is a Dallas-based healthcare accelerator founded in 2013 to address the need for a health innovation hub in the Dallas-Fort Worth Metroplex [9]. The accelerator has grown to become one of the region's most impactful healthcare innovation programs, having supported over 130 portfolio companies that have collectively raised more than $350 million in follow-on funding. Health Wildcatters' 10-week accelerator program runs annually from September to November, admitting 8 to 12 startups per cohort who receive seed investment and access to an extensive mentor network.

The accelerator's mentor network comprises over 200 mentors spanning the healthcare industry, professional services, and related verticals. This comprehensive network provides portfolio companies with guidance on clinical validation, regulatory strategy, payer and provider introductions, and commercial development. Health Wildcatters maintains partnerships with numerous organizations including Texas Health Resources, UTA (University of Texas at Arlington), AWS (Amazon Web Services), and various professional service firms that provide in-kind support to portfolio companies.

The accelerator's program structure is specifically designed for healthcare startups, recognizing the unique challenges of developing and commercializing healthcare technology. The application process is competitive, with the accelerator seeking companies that can benefit significantly from their clinical validation support and payer/provider network. For DFW-based healthcare AI companies seeking structured support, seed investment, and access to healthcare industry expertise, Health Wildcatters represents the region's premier accelerator option.

**Program Details:**
- **Program Duration:** 10 weeks (September-November annually)
- **Cohort Size:** 8-12 startups
- **Seed Investment:** Amount not publicly specified
- **Mentor Network:** 200+ mentors
- **Portfolio Companies:** 130+
- **Total Funds Raised by Portfolio:** $350+ million

**Contact Information:**
- **Address:** 3000 Pegasus Park Drive Suite 1330, Dallas, TX 75247
- **Website:** healthwildcatters.com
- **Application:** Via accelerator page on website

#### TechFW (Fort Worth)

TechFW is a Fort Worth-based accelerator that supports hardware and deeptech founders, making them relevant for healthcare AI companies developing physical products or medical devices [3]. While not exclusively healthcare-focused, TechFW's expertise in hardware development and technical product creation can benefit healthcare AI companies building solutions that combine software intelligence with physical components or medical devices.

The accelerator's Fort Worth location provides DFW healthcare AI companies with alternative accelerator options beyond Dallas-based programs. TechFW's focus on deeptech suggests openness to healthcare AI companies whose technology is based on novel scientific approaches or engineering innovations. For healthcare AI companies in the western DFW region or those with significant hardware components to their solutions, TechFW merits consideration as an accelerator option.

**Contact Information:**
- **Location:** Fort Worth, TX
- **Focus:** Hardware and deeptech founders

#### Capital Factory - Dallas

Capital Factory operates a Dallas location that provides statewide mentors, angels, and defense/cyber connections for Texas startups [3]. While not exclusively healthcare-focused, the accelerator's Texas-wide network and Dallas presence make them relevant for healthcare AI companies seeking broad investor and mentor connections throughout the state. Capital Factory's emphasis on connecting founders with investors and mentors aligns with the needs of healthcare AI companies at various stages of development.

The accelerator's defense and cybersecurity connections may be particularly relevant for healthcare AI companies developing solutions with security or defense applications, or those seeking to leverage technologies developed for defense purposes in healthcare contexts. For DFW healthcare AI companies seeking broader Texas connections beyond the immediate DFW ecosystem, Capital Factory provides an effective pathway to statewide investor and mentor networks.

**Contact Information:**
- **Location:** Dallas, TX
- **Focus:** Statewide mentor and investor connections

#### MassChallenge Texas (North Texas)

MassChallenge Texas offers equity-free acceleration for startups in the North Texas region, providing healthcare AI companies with an alternative accelerator model that does not require equity exchange [3]. This approach is particularly attractive for healthcare AI companies that wish to preserve ownership while gaining access to mentorship, programming, and investor connections. MassChallenge's global brand and network provide participants with exposure beyond the Texas market, potentially facilitating partnerships and investments from national and international sources.

The equity-free model is especially valuable for healthcare AI companies that may have received grant funding or non-dilutive capital and wish to minimize dilution at early stages. MassChallenge Texas's North Texas focus ensures that the program is accessible to DFW healthcare AI companies without requiring relocation, while still providing access to the organization's broader resources and network.

**Contact Information:**
- **Location:** North Texas
- **Focus:** Equity-free acceleration

---

## Part II: National Healthcare AI Investors and Venture Capital Firms

The national healthcare AI investment landscape has experienced unprecedented growth, with healthcare AI startups raising $10.5 billion in venture capital funding in 2024, and healthcare AI spending reaching $1.4 billion in 2025—nearly tripling 2024's investment levels [10]. This section provides comprehensive coverage of the leading national venture capital firms, investors, and organizations actively investing in healthcare AI companies across the United States. The investors listed here represent a curated selection of the most active and influential healthcare AI-focused investors, including their investment focus areas, typical check sizes, contact information, and representative portfolio companies.

### 2.1 Leading Digital Health and Healthcare AI Venture Capital Firms

#### Andreessen Horowitz (a16z)

Andreessen Horowitz, commonly known as a16z, is one of the most prominent venture capital firms in Silicon Valley and actively invests in digital health and healthcare AI companies [11]. The firm's investment approach focuses on active engagement in digital health, technology platforms including horizontal infrastructure and full-stack tech-enabled services, and ex-founders who can relate to entrepreneur challenges. a16z is known for publishing comprehensive market maps on their blog that influence industry thinking and provide guidance to entrepreneurs on sector opportunities.

The firm's typical investment range for pre-seed and seed rounds is $1 million to $10 million, providing substantial capital for healthcare AI companies at early stages. a16z's portfolio in healthcare includes companies such as Omada, Komodo, Ribbon Health, Marley Medical, and Turquoise Health, demonstrating their appetite for AI-enabled healthcare solutions across various care delivery and administrative applications. The firm is led by co-founders Marc Andreessen and Ben Horowitz, with Justin Larkin serving as an initial contact point for healthcare entrepreneurs.

a16z's healthcare AI investment thesis emphasizes companies that can achieve uncapped upside potential through technology-enabled transformation of healthcare delivery or administration. For healthcare AI companies seeking marquee Silicon Valley investors with significant capital resources and operational expertise, a16z represents a top-tier target. The firm's willingness to invest across the healthcare AI landscape, from consumer-facing applications to enterprise solutions, provides flexibility for entrepreneurs developing diverse healthcare AI applications.

**Contact Information:**
- **Contact:** Justin Larkin (jlarkin@a16z.com)
- **Website:** a16z.com
- **Typical Check Size:** $1-10M (pre-seed and seed)
- **Portfolio Examples:** Omada, Komodo, Ribbon Health, Marley Medical, Turquoise Health

#### 7wireVentures

7wireVentures is an early-stage healthcare-focused venture capital firm that invests in companies enabling informed and connected health consumers [11]. The firm's investment approach emphasizes partnering with amazing leaders—specifically healthcare operators who get in the trenches with founders to help build successful companies. This operational orientation distinguishes 7wireVentures from investors who provide primarily capital without hands-on involvement.

The firm's typical investment range is $4-6 million per company, positioning them as meaningful investors in seed and Series A rounds. 7wireVentures' portfolio includes Livongo (a pioneering chronic disease management platform that achieved significant success) and Caraway (a consumer-focused healthcare company), demonstrating their interest in both enterprise and consumer-facing healthcare applications. The firm's focus on informed connected health consumers aligns with the broader healthcare industry trend toward patient engagement and consumerization of healthcare.

For healthcare AI companies developing solutions that empower patients or consumers in their healthcare journey, 7wireVentures represents a particularly aligned investor. The firm's operator-focused approach can provide significant value to healthcare AI companies navigating the complex healthcare market landscape. Initial outreach should be directed to the firm's general inquiry email address.

**Contact Information:**
- **Contact:** tunde@7wireventures.com
- **Website:** 7wireventures.com
- **Typical Check Size:** $4-6M
- **Portfolio Examples:** Livongo, Caraway

#### Rock Health

Rock Health operates as both a venture fund and an advisory firm dedicated to accelerating digital health innovation [11]. The organization's unique model bridges the knowledge gap between early innovators and major corporations, providing strategic insights into the healthcare industry while making direct investments. Rock Health's investment focus centers on software and data-driven business models in healthcare, with a particular emphasis on founders who demonstrate drive, confidence, and humility.

The firm's typical investment range is $500,000 to $5 million per company, with approximately 4-5 deals per year. Rock Health is notably selective about their investments, focusing on companies that can benefit from their extensive corporate network and healthcare industry expertise. The organization does not invest in services-only businesses, drugs, or pure-play diagnostics and medical devices, focusing instead on technology-enabled solutions that can scale efficiently.

Rock Health's portfolio includes Omada Health and Collective Health, both of which have achieved significant success in digital health. The organization's advisory practice provides additional resources for understanding healthcare market dynamics and corporate partnership opportunities. For healthcare AI companies seeking investors with deep healthcare industry expertise and extensive corporate connections, Rock Health represents an excellent option. Initial contact should be directed to venture@rockhealth.com or General Partner Bill Evans.

**Contact Information:**
- **Contact:** venture@rockhealth.com, bill@rockhealth.com (General Partner Bill Evans)
- **Website:** rockhealth.com
- **Typical Check Size:** $500K-$5M
- **Annual Deal Volume:** 4-5 deals
- **Portfolio Examples:** Omada Health, Collective Health

#### Digital Health Venture Partners (DHVP)

Digital Health Venture Partners is a seed-stage venture capital firm headquartered in Washington, D.C., that invests exclusively in healthcare software and AI-enabled services companies [12]. The firm partners with founders developing technologies, products, and services that solve healthcare problems, create access, transform patient care and outcomes, and reduce the cost of healthcare delivery. DHVP's investment sectors span software (AI/SaaS), AI-enabled services, and healthcare consumerism.

The firm is led by Founder and General Partner Arvin Grover, along with Partner Steve Yaskin and Advisor Dan Cimaglia. DHVP can lead investment rounds or participate as part of a syndicate, providing flexibility for healthcare AI companies at various stages of fundraising. The firm's portfolio demonstrates a strong focus on AI applications across the healthcare continuum, including ArcHouse (healthcare technology for hospice operations), Avo (clinical workflow tools), BeHuman Health (AI-driven cancer screenings), and numerous other AI-enabled healthcare solutions.

DHVP's portfolio also includes notable prior investments such as Suki (AI-driven digital assistant for administrative tasks), Health Gorilla (national interoperability platform), and Luma (patient journey automation platform), demonstrating their track record of supporting successful healthcare AI companies through their growth trajectories. The firm's exclusive focus on healthcare software and AI-enabled services ensures deep sector expertise and relevant network connections for portfolio companies.

**Contact Information:**
- **Email:** info@dhvp.io
- **Website:** dhvp.io
- **Location:** Washington, D.C.
- **Key Contacts:** Arvin Grover (Founder & GP), Steve Yaskin (Partner)
- **Portfolio Examples:** ArcHouse, Avo, BeHuman Health, Suki, Health Gorilla, Luma

#### Healthy Ventures

Healthy Ventures is a seed-stage venture capital firm focused exclusively on digital health technologies and companies building solutions that scale healthcare [11]. The firm's investment approach emphasizes team capabilities, specifically the ability to adapt and evolve as market conditions change. Healthy Ventures combines pure healthcare and pure technology operating and investing backgrounds, providing portfolio companies with perspectives that bridge clinical innovation and technology development.

The firm's typical investment range is $1-3 million at seed and pre-seed stages, positioning them as meaningful early investors for healthcare AI companies. Healthy Ventures' investment thesis encompasses every area of digital health except therapeutics and straight healthcare services—they do invest in tech-enabled services that leverage technology to transform service delivery. The firm's portfolio includes Season Health (nutrition-focused healthcare) and Concert Health (behavioral health integration), demonstrating their interest in AI-enabled solutions that address specific healthcare delivery challenges.

For healthcare AI companies seeking investors who understand both the healthcare industry and technology company building, Healthy Ventures represents an excellent option. The firm's selective investment approach means they are looking for exceptional teams and market opportunities, making them a high-value target for qualified healthcare AI entrepreneurs. Initial outreach should be directed to pitch@healthy.vc.

**Contact Information:**
- **Contact:** pitch@healthy.vc
- **Website:** healthy.vc
- **Typical Check Size:** $1-3M
- **Portfolio Examples:** Season Health, Concert Health

#### Virtue VC

Virtue VC is an early-stage venture capital firm that exclusively partners with pre-seed and seed healthcare founders [11]. The firm focuses on what they term the "business of care"—encompassing data, dollars, and delivery of care—in contrast to traditional life sciences, therapeutics, medical devices, or biotech investments. This distinctive focus positions Virtue VC as a specialized investor for healthcare AI companies developing solutions that address the business operations and economics of healthcare delivery.

The firm's typical investment range is $500,000 to $1 million, making them a meaningful investor for companies at the earliest stages of development. Virtue VC's portfolio includes Nomi Health (healthcare pricing and access platform) and Evvy (women's health testing and insights), demonstrating their interest in solutions that bring transparency and innovation to healthcare business models. The firm's exclusive healthcare focus and early-stage focus combine to create deep expertise in the challenges facing healthcare AI companies at formation and early growth stages.

For healthcare AI companies developing solutions that transform how healthcare is delivered, priced, or accessed, Virtue VC represents a particularly aligned investor. Initial outreach should be directed to Sean Doolan at sd@virtuevc.com.

**Contact Information:**
- **Contact:** Sean Doolan (sd@virtuevc.com)
- **Website:** virtuevc.com
- **Typical Check Size:** $500K-$1M
- **Portfolio Examples:** Nomi Health, Evvy

#### Define Ventures

Define Ventures is a venture capital firm that partners with entrepreneurs who have digital health focus and expertise to reimagine healthcare [11]. The firm's investment approach emphasizes strategic vision and the ability to build meaningful companies that address significant healthcare challenges. Define Ventures invests across all areas of digital health, providing flexibility for entrepreneurs developing diverse healthcare AI applications.

The firm's typical investment range is $1-20 million, demonstrating significant flexibility across funding stages and company needs. Define Ventures' partners have been involved with successful healthcare companies including Livongo, HIMS, and Unite Us, providing the firm with operational experience and network connections that extend beyond capital provision. The firm's willingness to invest at various stages makes them suitable for healthcare AI companies at different development phases seeking growth capital.

For healthcare AI companies seeking investors with proven track records in digital health and the capacity to provide meaningful capital at multiple stages, Define Ventures represents an excellent option. Initial outreach should be directed to Lynne O'Keefe (Lynne@definevc.com) or Hong Truong (hong@definevc.com).

**Contact Information:**
- **Contact:** Lynne O'Keefe (Lynne@definevc.com), Hong Truong (hong@definevc.com)
- **Website:** definevc.com
- **Typical Check Size:** $1-20M
- **Portfolio Examples:** Livongo, HIMS, Unite Us (from previous partner experience)

#### General Catalyst

General Catalyst is a venture capital firm that makes early-stage and transformational investments in technology companies and market-leading businesses [11]. The firm's healthcare investment thesis centers around their "Health Assurance" vision—a resilient, proactive healthcare system that bends the cost curve while improving quality, access, equity, and affordability. This comprehensive vision encompasses software, services, and life sciences investments, providing broad scope for healthcare AI companies.

The firm demonstrates tremendous flexibility in investment sizes and stages, preferring to lead investments with ownership commensurate with their level of involvement. General Catalyst invests from seed through pre-IPO stages, making them a potential partner throughout a healthcare AI company's growth trajectory. The firm is led by Managing Director Holly Maloney and Associate Mo Punjwani, who focus on healthcare investments and are appropriate initial contacts for healthcare AI entrepreneurs.

For healthcare AI companies seeking investors with transformational vision, significant capital resources, and a long-term partnership approach, General Catalyst represents a top-tier option. The firm's Health Assurance thesis aligns with healthcare AI applications that can fundamentally improve healthcare system performance and patient outcomes.

**Contact Information:**
- **Contact:** Holly Maloney (holly@generalcatalyst.com), Mo Punjwani (mpunjwani@generalcatalyst.com)
- **Website:** generalcatalyst.com
- **Typical Check Size:** Flexible (seed to pre-IPO)
- **Portfolio Examples:** Flexpa, Lottie (seed investments)

### 2.2 Established Healthcare-Focused Venture Capital Firms

#### Deerfield Management

Deerfield Management is a New York-based healthcare investment firm founded in 1994 that invests across multiple stages from seed through post-IPO [13]. The firm's investment focus spans health care, health insurance, and information services, providing diversified opportunities for healthcare AI companies at various development stages. Deerfield's long history in healthcare investing demonstrates sustained commitment to the sector and deep industry expertise.

The firm's investment stage flexibility—spanning seed, early stage venture, late stage venture, and post-IPO—makes them suitable for healthcare AI companies at any phase of growth. Deerfield's portfolio includes notable healthcare companies such as Nuvalent, Viatris, Neurocrine Biosciences, and Centene Corporation, demonstrating their capacity to support companies across the healthcare spectrum. For healthcare AI companies seeking established healthcare investors with broad stage flexibility and extensive industry networks, Deerfield represents an excellent option.

**Contact Information:**
- **Website:** deerfield.com
- **Location:** New York, NY
- **Founded:** 1994
- **Investment Stages:** Seed, Early Stage Venture, Late Stage Venture, Post-IPO
- **Focus Areas:** Health Care, Health Insurance, Information Services

#### Silversmith Capital Partners

Silversmith Capital Partners is a Boston-based venture capital firm founded in 2015 that focuses on healthcare and technology investments [13]. The firm's investment stages span seed through private equity, providing flexibility for companies at various growth phases. Silversmith's portfolio includes companies across healthcare and technology sectors, including notable investments in platforms that have achieved significant scale.

The firm's healthcare focus combined with technology investment experience makes them well-suited for healthcare AI companies that require both healthcare domain expertise and technology scaling capabilities. Silversmith's Boston location positions them within one of the world's leading healthcare and technology innovation ecosystems, providing access to talent, expertise, and potential customers for portfolio companies.

**Contact Information:**
- **Website:** silversmith.com
- **Location:** Boston, MA
- **Founded:** 2015
- **Investment Stages:** Seed, Early Stage Venture, Late Stage Venture, Private Equity
- **Focus Areas:** Health Care, Information Technology, Information Services

#### New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is one of the world's largest and most active venture capital firms, headquartered in Menlo Park, California, and founded in 1977 [13]. The firm's investment scope spans healthcare, technology, consumer, and financial services, with healthcare representing a significant portion of their investment activity. NEA's investment stages include early stage venture, late stage venture, post-IPO, and debt, providing comprehensive capital solutions for growing companies.

NEA's healthcare portfolio includes companies such as Tesaro (acquired by GlaxoSmithKline), Acadia Pharmaceuticals, and numerous other successful healthcare companies. The firm's substantial capital resources and global network make them a valuable partner for healthcare AI companies with ambitions for significant scale and international expansion. NEA's track record of successful healthcare investments spans decades, demonstrating sustained commitment and expertise in the sector.

**Contact Information:**
- **Website:** nea.com
- **Location:** Menlo Park, CA
- **Founded:** 1977
- **Investment Stages:** Early Stage Venture, Late Stage Venture, Post-IPO, Debt
- **Focus Areas:** Health Care, Technology, Consumer, Financial Services

#### Vivo Capital

Vivo Capital is a Palo Alto-based healthcare-focused investment firm founded in 1996 that manages approximately $5.8 billion in assets [13]. The firm invests across early stage venture, late stage venture, post-IPO, and private equity stages, with exclusive focus on healthcare investments. Vivo's substantial assets under management demonstrate significant capital availability for healthcare AI companies at various stages.

The firm's healthcare-exclusive focus ensures deep sector expertise and relevant network connections for portfolio companies. Vivo's portfolio includes companies such as Soleno Therapeutics, Verona Pharma, Geron Corporation, and Avadel Pharmaceuticals, demonstrating their interest in innovative healthcare approaches across therapeutics and medical technologies. For healthcare AI companies seeking well-capitalized healthcare-only investors with global reach and extensive industry networks, Vivo Capital represents an excellent option.

**Contact Information:**
- **Website:** vivocapital.com
- **Location:** Palo Alto, CA
- **Founded:** 1996
- **Assets Under Management:** Approximately $5.8 billion
- **Investment Stages:** Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity
- **Focus Areas:** Health Care

#### SV Health Investors

SV Health Investors is a Boston-based healthcare venture capital firm founded in 1993 that focuses on biotechnology, healthcare, life science, and medical device investments [13]. The firm's investment stages span seed through debt, providing comprehensive capital solutions for healthcare companies at various development phases. SV Health Investors' long history in healthcare investing demonstrates sustained expertise and commitment to the sector.

The firm's portfolio includes notable healthcare companies such as American Well (Amwell), Insulet Corporation, Achillion Pharmaceuticals, and Sutro Biopharma, demonstrating their capacity to support companies across the healthcare innovation spectrum. SV Health Investors' Boston location positions them within one of the world's leading healthcare innovation clusters, providing access to world-class research institutions, clinical expertise, and talent pools.

**Contact Information:**
- **Website:** svhealthinvestors.com
- **Location:** Boston, MA
- **Founded:** 1993
- **Investment Stages:** Seed, Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity, Debt
- **Focus Areas:** Biotechnology, Health Care, Life Science, Medical Device

#### Third Rock Ventures

Third Rock Ventures is a Boston-based venture capital firm founded in 2007 that focuses exclusively on healthcare companies across biotechnology, healthcare, and medical device sectors [13]. The firm's investment stages span seed through post-IPO, providing flexibility for companies at various development phases. Third Rock's approach emphasizes building companies from the ground up, often founding or co-founding portfolio companies based on scientific innovation and market opportunity.

The firm's portfolio includes highly successful companies such as Sage Therapeutics, Editas Medicine, bluebird bio, and Global Blood Therapeutics, demonstrating their capacity to identify and build category-leading healthcare companies. Third Rock's collaborative approach with founders and their willingness to engage with companies at the earliest stages make them particularly attractive for healthcare AI companies with strong scientific foundations and ambitious visions.

**Contact Information:**
- **Website:** thirdrockventures.com
- **Location:** Boston, MA
- **Founded:** 2007
- **Investment Stages:** Seed, Early Stage Venture, Late Stage Venture, Post-IPO
- **Focus Areas:** Biotechnology, Health Care, Medical Device

### 2.3 Specialized Healthcare AI and Digital Health Investors

#### Lux Capital

Lux Capital is a venture capital firm known for making long-term bets on contrarians, scientists, technologists, and inventors who challenge the status quo [11]. The firm's healthcare investments span digital therapeutics, care delivery, value-based care, software for research and development, and other areas where technology can transform healthcare. Lux Capital's investment sizes range from pre-seed through pre-IPO stages, demonstrating significant flexibility for companies at various growth phases.

The firm's investment approach emphasizes founder quality and the potential for breakthrough impact. Lux Capital's healthcare portfolio includes companies such as Alife (AI-assisted fertility treatment) and Summer Health (pediatric care platform), demonstrating their interest in AI-enabled healthcare solutions across diverse clinical applications. The firm is led by partners including Deena Shakir, who is a specific contact for healthcare AI companies. For healthcare AI companies seeking investors who appreciate contrarian approaches and long-term vision, Lux Capital represents an excellent option.

**Contact Information:**
- **Contact:** Deena Shakir or any investor at Lux Capital
- **Website:** luxcapital.com
- **Investment Range:** Wide range (pre-seed to pre-IPO)
- **Portfolio Examples:** Alife, Summer Health

#### Susa Ventures

Susa Ventures is an early-stage venture capital firm that invests in businesses with strong compounding moats based on proprietary data, economies of scale, or network effects [11]. The firm provides capital, customers, and community to portfolio companies, with exceptional capabilities in helping seed-stage founders raise Series A funding. Susa Ventures invests broadly in digital health, including care coordination and delivery, data integration and analytics, clinical infrastructure and workflows, and finance operations and insurance.

The firm's typical investment range is $1-3 million at seed and pre-seed stages, positioning them as meaningful early investors. Susa Ventures' healthcare portfolio includes companies such as Photon and The Wound Co, demonstrating their interest in AI-enabled solutions that address specific clinical needs. The firm tends not to invest in pure life science and biotech companies, focusing instead on technology-enabled healthcare solutions. For healthcare AI companies seeking investors with strong Series A preparation capabilities and network effects in healthcare, Susa Ventures represents a compelling option. Initial outreach should be directed to Derick En'Wezoh, MD at derick@susaventures.com.

**Contact Information:**
- **Contact:** Derick En'Wezoh, MD (derick@susaventures.com)
- **Website:** susaventures.com
- **Typical Check Size:** $1-3M (seed and pre-seed)
- **Portfolio Examples:** Photon, The Wound Co

#### Lerer Hippeau

Lerer Hippeau is an early-stage venture capital firm known for investing in entrepreneurs with great ideas, good people, and strong community contributions [11]. The firm is itself operated by investors who were formerly founders, enabling them to provide relevant guidance to portfolio companies. Lerer Hippeau invests early and stays with companies throughout their growth, demonstrating commitment to long-term partnership.

The firm's typical investment range is $500,000 to $2 million, positioning them as meaningful early investors. Lerer Hippeau invests in all areas of digital health, providing flexibility for healthcare AI companies developing diverse applications. The firm's New York base positions them within a major healthcare and technology hub, providing access to talent, expertise, and potential partners. For healthcare AI companies seeking investors who understand the founder journey and can provide sustained support, Lerer Hippeau represents an excellent option.

**Contact Information:**
- **Contact:** Graham Brown, Partner
- **Website:** lererhippeau.com
- **Typical Check Size:** $500K-$2M
- **Portfolio Examples:** K Health, Guideline, MIRROR

#### RH Capital (Rhia Ventures)

RH Capital is a venture capital fund affiliated with Rhia Ventures that focuses on early-stage, high-impact companies driving innovation, access, and equity across the reproductive and maternal health landscape [11]. The firm's investment focus emphasizes the ability to address significant unmet needs in women's health, with deep expertise in this historically underserved area of healthcare. RH Capital invests across life sciences, digital health, health services, and consumer sectors with a women's health focus.

The firm's typical investment range is $250,000 to $1 million for initial checks, with reserves for follow-on investment. RH Capital's portfolio includes Ovia and Nurx, demonstrating their interest in digital health solutions that address women's health needs. For healthcare AI companies developing solutions for reproductive health, maternal care, or other women's health applications, RH Capital represents a particularly aligned investor with deep sector expertise and commitment.

**Contact Information:**
- **Contact:** Thomya Goode
- **Website:** rhiacapital.com
- **Typical Check Size:** $250K-$1M (initial), with reserves for follow-on
- **Portfolio Examples:** Ovia, Nurx

#### Flare Capital

Flare Capital is an early-stage and emerging growth investor focused on healthcare technology innovation [11]. The firm emphasizes team quality and deep relationships with healthcare strategics, providing portfolio companies with meaningful partnership opportunities. Flare Capital invests in healthtech and related healthcare services, with typical check sizes ranging from $100,000 to $10 million, demonstrating significant flexibility across investment stages.

The firm's healthcare portfolio includes companies such as Bright Health, Circulation, ClearDATA, HealthVerity, Iora Health, Valence Health, and Welltok. Flare Capital also maintains a strategic partnership with Rock Health, providing portfolio companies with access to an extended network of healthcare industry resources. For healthcare AI companies seeking investors with extensive healthcare strategic relationships and flexible investment capacity, Flare Capital represents an excellent option.

**Contact Information:**
- **Contact:** Margaret Malone
- **Website:** flarecapital.com
- **Typical Check Size:** $100K-$10M
- **Portfolio Examples:** Bright Health, Circulation, ClearDATA, HealthVerity, Iora Health

#### Overwater Ventures

Overwater Ventures is an early-stage venture capital firm that leads or co-leads pre-seed to seed investments [11]. The firm focuses on amazing teams and helping founders turn breakthrough tech or science into scalable businesses. Most of their investments are in B2C or B2B2C companies with a science or technology advantage, including women's health, family health, cancer and diseases, neuro, and longevity sectors.

The firm's typical investment range is $100,000 to $2 million, positioning them as meaningful early investors. Overwater Ventures does not invest in traditional pharmaceutical companies, focusing instead on technology-enabled solutions that address significant healthcare needs. The firm's portfolio includes Overture Life, Conceive, Fellow, and RTHM, demonstrating their interest in reproductive health and related applications. For healthcare AI companies developing consumer-facing or technology-enabled solutions with scientific foundations, Overwater Ventures represents an excellent option. Initial outreach should be directed to Kristina Simmons Southwark at kristina@overwater.vc.

**Contact Information:**
- **Contact:** Kristina Simmons Southwark (kristina@overwater.vc)
- **Website:** overwater.vc
- **Typical Check Size:** $100K-$2M
- **Portfolio Examples:** Overture Life, Conceive, Fellow, RTHM

#### Jazz Venture Partners

Jazz Venture Partners invests in companies that extend the boundaries of human performance—improving how we live, learn, work, play, and experience the world [11]. The firm seeks breakthroughs at the frontiers of technology and science, including AI, neurobiology, AR, and closed-loop human-computer systems. Jazz Venture Partners focuses on exceptional teams tackling markets with great potential, with particular interest in sustainable well-being and digital medicine.

The firm's investment range is $500,000 to $25 million, demonstrating significant flexibility across company stages. Jazz Venture Partners' Sustainable Well-being focus encompasses consumer and B2B applications for human performance, while their Digital Medicine focus emphasizes clinically validated software therapeutics. The firm does not invest in traditional pharmaceuticals, focusing instead on technology-enabled therapeutic solutions. Jazz Venture Partners' portfolio includes Woebot Health, Applied VR, OMA Fertility, Akili, and Pear Therapeutics, demonstrating their track record of successful digital medicine investments.

**Contact Information:**
- **Contact:** Amanda Way (amanda@jazzvp.com)
- **Website:** jazzvp.com
- **Typical Check Size:** $500K-$25M
- **Portfolio Examples:** Woebot Health, Applied VR, OMA Fertility, Akili, Pear Therapeutics

### 2.4 Angel Investors and Syndicates

#### HealthTech Capital

HealthTech Capital is an active early-stage investor vertically focused on HealthTech startups within the healthcare sector [14]. The organization operates as a membership comprising accredited angel investors, healthcare systems, venture investors, corporate investors, successful entrepreneurs, executives, and clinicians. This diverse membership provides portfolio companies with access to varied perspectives and networks across the healthcare industry.

Corporate members of HealthTech Capital are interested in potential market collaboration and provide corporate funding, enabling portfolio companies to access strategic partnerships alongside capital investment. The organization's portfolio companies have attracted over $1 billion in follow-on capital from leading venture and corporate investors, demonstrating their effectiveness in preparing companies for subsequent funding rounds. Entrepreneurs seeking funding can submit their plans through the organization's application portal.

**Contact Information:**
- **Application Portal:** Available through Dealum platform
- **Website:** healthtechcapital.com
- **Follow-on Capital Raised by Portfolio:** Over $1 billion

#### Looking Glass Capital

Looking Glass Capital invests in mission-driven founders building enterprise and consumer-facing companies across health, climate, and empowerment [11]. The firm focuses on deep understanding of markets and major players, maintaining a deep roster of complementary portfolio companies that can provide mutual support. Looking Glass Capital's healthcare focus includes vertical specialty care, digital therapeutics, and healthcare IT and infrastructure.

The firm's typical investment range is $300,000 to $500,000, positioning them as meaningful early investors. Looking Glass Capital does not invest in hardware, life sciences, or biotech per se, focusing instead on software and technology-enabled solutions. The firm's portfolio includes Hone Health and Sylvan Health, demonstrating their interest in AI-enabled healthcare solutions. For healthcare AI companies seeking investors with mission-driven orientation and deep market understanding, Looking Glass Capital represents an excellent option. Initial outreach should be directed to Adam Besvinick at adam@lookingglass.vc.

**Contact Information:**
- **Contact:** Adam Besvinick (adam@lookingglass.vc)
- **Website:** lookingglass.vc
- **Typical Check Size:** $300-500K
- **Portfolio Examples:** Hone Health, Sylvan Health

---

## Part III: Healthcare Accelerators and Incubation Programs

Healthcare accelerators provide structured programs, funding, mentorship, and networking opportunities that can accelerate the development and commercialization of healthcare AI companies. This section details the leading healthcare-focused accelerator programs available to healthcare AI startups, including program specifics, investment amounts, focus areas, and application processes.

### 3.1 Non-Dilutive Funding Programs

#### National Science Foundation (NSF) SBIR Program

The National Science Foundation offers SBIR (Small Business Innovation Research) Grants for early-stage research and development, providing non-dilutive funding that enables startups to retain full control, direction, and intellectual property [15]. The NSF focuses on deep technologies based on fundamental science and engineering discoveries, with specific interest in digital health and biomedical technologies. The program's investment amounts range from $275,000 to $2,000,000 per startup, with the NSF investing approximately $200 million annually to approximately 400 startups.

The NSF SBIR program's evaluation criteria emphasize impact, technological innovation, market pull, and ability to scale. This non-dilutive funding model is particularly valuable for healthcare AI companies that may be developing novel algorithms or technologies that require extended research timelines before generating revenue. The program's focus on translating fundamental science into commercial applications aligns well with healthcare AI companies that have strong scientific foundations.

**Program Details:**
- **Typical Investment Size:** $275,000-$2,000,000 (non-dilutive)
- **Annual Investment:** Approximately $200 million annually
- **Companies Funded:** Approximately 400 startups per year
- **Focus Areas:** Digital Health, Biomedical Technologies, Deep Technologies

**Contact Information:**
- **Website:** nsf.gov
- **Multiple Program Directors available (via SBIR funding guides)

#### National Institutes of Health (NIH) SBIR Program

The NIH SBIR program is the largest source of early-stage capital for life sciences in the United States, providing non-dilutive funds for small business research and development [15]. The program focuses on life sciences, medical, healthcare technology, and investigational tools, with investment amounts ranging from $300,000 to $3,000,000 (non-dilutive). The NIH invests over $1.2 billion annually, funding approximately 850 deals per year.

The NIH SBIR program's evaluation criteria emphasize impact, technological innovation, market pull, and ability to scale, supporting research and development of deep technologies that address significant healthcare needs. For healthcare AI companies developing solutions with clinical applications or that require rigorous scientific validation, NIH funding can provide essential non-dilutive capital while maintaining equity for founders.

**Program Details:**
- **Typical Investment Size:** $300,000-$3,000,000 (non-dilutive)
- **Annual Investment:** Over $1.2 billion annually
- **Companies Funded:** Approximately 850 deals per year
- **Focus Areas:** Life Sciences, Medical, Healthcare Technology

**Contact Information:**
- **Website:** nih.gov
- **Multiple Program Officers available (via NIH SEED contact page)

### 3.2 Equity-Based Accelerator Programs

#### Medtech Innovator

Medtech Innovator is a leading accelerator for early- to mid-stage medical device, diagnostic, or digital health companies that have not yet closed a Series B round [15]. The accelerator program runs from June (Summit in San Francisco) to October (The MedTech Conference in Boston), providing networking, workshops, and pitching opportunities to investors, manufacturers, and providers. Selected companies receive mentorship from corporate partners and complimentary AdvaMed Accel membership.

The accelerator provides up to $500,000 in non-dilutive cash prizes and awards, including incubator space from Johnson & Johnson Innovation – JLABS. This comprehensive support package makes Medtech Innovator one of the most well-resourced healthcare accelerators available. The program's competitive selection process identifies companies with strong potential for healthcare technology innovation and commercial success.

**Program Details:**
- **Program Timeline:** June to October annually
- **Investment:** Up to $500,000 in non-dilutive cash prizes
- **Focus:** Medical device, diagnostic, digital health (pre-Series B)
- **Portfolio Examples:** Cooler Heads, Pops Diabetes Care, Senzo, Tasso, Sana Labs

**Contact Information:**
- **Website:** medtechinnovator.com

#### Cedars-Sinai Accelerator

The Cedars-Sinai Accelerator is a 3-month program based in Los Angeles, California, designed to transform healthcare by helping early-stage companies bring innovative technology products to market [16]. The program provides a $100,000 convertible debt note with a $5 million cap and no discount, along with extensive mentorship from over 300 leading Cedars-Sinai clinicians and executives. The accelerator's small class sizes enable customized approaches based on each company's specific needs.

The program's three-phase structure provides progressive support: mentor engagement and feedback in month one, guidance on product and market fit in month two, and fundraising preparation culminating in Demo Day in month three. Cedars-Sinai's technical support team of 600+ IT professionals provides design, testing, EHR integration, workflow, digital strategy, and virtual services support. The program requires at least one founder to be consistently involved and spend most time on-site in Los Angeles.

**Program Details:**
- **Duration:** 3 months
- **Investment:** $100,000 convertible debt note ($5M cap, no discount)
- **Mentor Network:** 300+ clinicians and executives
- **Location:** Los Angeles, California
- **Focus:** Digital health, medical devices, biotech, pharmaceutical products

**Contact Information:**
- **General Inquiries:** csaccelerator.com/connect
- **Key Contacts:** Samantha Shobash (samantha.shobash@cshs.org), Omar Perez (omar.perez@cshs.org), Jeremy Roseman (Jeremy.Roseman@cshs.org), Janny Hsu (Janny.Hsu@cshs.org), Rithik Jain (Rithik.Jain@cshs.org)
- **Application:** csaccelerator.com/program (via F6S application form)

#### PharmStars

PharmStars is a 10-week pharma-focused accelerator that educates and mentors digital health startups for engagement with pharmaceutical and biotech firms [15]. The program is equity-free, requiring a $2,500 program fee paid by participating startups. PharmStars is supported by pharma members committed to working with graduating startups, providing meaningful partnership opportunities for companies seeking pharmaceutical industry relationships.

The program focuses on digital health adoption to improve patient outcomes and is designed for startups with a prototype or product ready for pharma engagement. PharmStars' specialized focus makes it particularly valuable for healthcare AI companies developing solutions that could integrate with pharmaceutical company products, services, or clinical development programs.

**Program Details:**
- **Duration:** 10 weeks
- **Investment:** Equity-free ($2,500 program fee)
- **Focus:** Digital health for pharma engagement
- **Ideal For:** Companies with prototypes ready for pharma partnerships

**Portfolio Examples:** Nori Health, Liyfe, Prsim Analytic Technologies, Tag.bio

#### Startup+Health

Startup+Health operates a unique investment model supporting entrepreneurs at any stage from pre-seed to Series A [15]. The program invests in "Health Transformers" globally, focusing on 12 "Health Moonshots" that represent ambitious goals for healthcare transformation. For seed companies, the program offers a $200,000+ benefit package including a $20,000 cash stipend in exchange for 2% equity using a post-money SAFE.

The program's portfolio spans 27 countries and six continents, demonstrating their global reach and commitment to healthcare innovation worldwide. Startup+Health's comprehensive support model includes funding, mentorship, and network access that can accelerate healthcare AI company development regardless of geographic location.

**Program Details:**
- **Investment:** $200,000+ benefit package ($20K cash stipend) for 2% equity
- **Stage:** Pre-seed, Seed, Series A
- **Portfolio Reach:** 27 countries, 6 continents
- **Focus:** 12 Health Moonshots

**Portfolio Examples:** Hurdle, Gennev, Gabbi, Doctor.com, AdhereTech, Babyscripts, Cecila Health

#### StartX Med

StartX Med is a medical vertical of StartX designed to accelerate Stanford's top medical entrepreneurs through experiential education and collective intelligence [15]. The program is equity-free and focuses on idea and early-stage companies with a strong emphasis on Stanford-affiliated founders. Non-Stanford affiliates can participate as "Visiting Founders," providing access to the program's resources for qualified companies outside the Stanford ecosystem.

The program's experiential education approach provides hands-on learning and mentorship from experienced healthcare entrepreneurs and industry experts. For healthcare AI companies with Stanford connections or those seeking access to Stanford's innovation ecosystem, StartX Med represents a valuable accelerator option.

**Program Details:**
- **Duration:** Not specified (experiential program)
- **Investment:** Equity-free
- **Focus:** Stanford-affiliated medical entrepreneurs
- **Access:** Non-Stanford companies can join as Visiting Founders

**Portfolio Examples:** Lark, Remedly, Tombot, Spect

---

## Part IV: Healthcare Pitch Competitions

Healthcare pitch competitions provide opportunities for healthcare AI companies to gain visibility, prizes, and connections with investors and industry leaders. This section details the leading healthcare pitch competitions relevant to healthcare AI startups.

### 4.1 Major Healthcare Pitch Competitions

#### MedTech Color Pitch Competition

The MedTech Color Pitch Competition partners with MedTech Innovator to support early-stage medical device and technology companies, with a focus on diversifying Medtech by providing resources, mentorship, and funding to founders [17]. Since 2021, the program has awarded over $1.1 million in non-dilutive funding and in-kind resources to portfolio companies. The competition serves both Seed and Series A-ready companies, providing meaningful opportunities for healthcare AI companies at various development stages.

The 2024 competition awarded first place prizes of $75,000, second place of $50,000, third place of $25,000, and a Community Impact Prize of $5,000. Winners also have the opportunity to compete for $500,000 in non-dilutive funding through the MedTech Innovator Road Tour partnership and a chance to join the prestigious MedTech Innovator Accelerator. The program's impact is demonstrated by over 30 companies invested in, $25.3 million raised from investors, and two companies acquired.

**Competition Details:**
- **First Place Prize:** $75,000
- **Second Place Prize:** $50,000
- **Third Place Prize:** $25,000
- **Community Impact Prize:** $5,000
- **Additional Opportunity:** Up to $500,000 through MedTech Innovator Road Tour
- **Since 2021:** Over $1.1 million awarded, 30 companies invested in

**Contact Information:**
- **General Inquiries:** info@medtechcolor.org
- **Sponsorship:** Katrina Holland (Katrina.Holland@medtechcolor.org)
- **Website:** medtechcolor.org/pitch_competition

#### MEDICA START-UP COMPETITION

The MEDICA START-UP COMPETITION is in its 14th year seeking outstanding innovations in digital health to provide valuable connections and worldwide visibility for participating startups [18]. The competition is specifically focused on digital health, including submission categories such as AI in healthcare, robotics, health apps, and lab diagnostics. Selected companies are recognized as among the "Top 15 Medical Start-ups" and present their solutions at the MEDICA INNOVATION FORUM.

The competition provides recognition, connections, and visibility for winning companies, with additional awards for first, second, third place, and a public vote winner. The MEDICA trade fair is one of the world's largest medical technology events, providing unparalleled visibility for winning companies. The competition is open to innovators from around the globe, with detailed application information available through the Innovation World Cup website.

**Competition Details:**
- **Recognition:** Top 15 Medical Start-ups (annual)
- **Awards:** 1st, 2nd, 3rd place + Public Vote Winner
- **Focus:** Digital Health (AI, robotics, health apps, lab diagnostics)
- **Visibility:** MEDICA INNOVATION FORUM presentation

**Contact Information:**
- **Program Management:** Dr. Sonja Sulzmaier, Managing Partner, Navispace GmbH (+49 8152 99886-23, s.sulzmaier@navispace.de)
- **Partner/Program:** Sarah Endepols, Project & Innovation Manager, Navispace GmbH (+49 1735 854 698, s.endepols@navispace.de)
- **Application:** innovationworldcup.com/medica-startup-competition/

#### Health Tech Challengers

Health Tech Challengers is a pitch competition organized by Futurae Media Ltd that features eight application tracks for innovative digital health startups [19]. The competition's 2025 iteration includes tracks focused on Connected Care, AI Supported Healthcare, TechBio, Disruptive Diagnostics, Chronic Disease Management, Consumer Tech & Wellness, Women's Health, and a Solving X (Wild Card) category for rule-breaking innovations.

The 2025 competition timeline includes application deadline on September 15, Top 80 announcement on October 1, and finals on December 3-4 at the Health Tech Forward conference. The Ultimate Winner receives recognition as the Health Tech Challenger, with previous winners including Adora Digital Health (2025). Each of the 80 finalists receives one complimentary ticket to Health Tech Forward 2025, providing additional networking and visibility opportunities.

**Competition Details:**
- **Application Deadline:** September 15, 2025
- **Top 80 Announcement:** October 1, 2025
- **Finals:** December 3-4, 2025 @ Health Tech Forward
- **Tracks:** 8 categories (Connected Care, AI Healthcare, TechBio, Diagnostics, Chronic Disease, Consumer Tech, Women's Health, Solving X)
- **Finalist Benefits:** 1 complimentary Health Tech Forward ticket

**Contact Information:**
- **General Inquiries:** challengers@futuraemedia.com
- **Info:** info@healthtechforward.com
- **Phone:** +44 7451 204362
- **Website:** healthtechchallengers.com

---

## Conclusion

This comprehensive directory provides healthcare AI entrepreneurs with actionable information about funding sources across the DFW metropolitan area and nationally. The DFW healthcare ecosystem has matured significantly, with $1.2 billion in healthcare funding in 2025 and a robust network of local investors, angel networks, and accelerators ready to support healthcare innovation. Health Wildcatters stands out as the region's premier healthcare accelerator, while SHD Partners and Green Park & Golf Ventures provide specialized venture capital for medtech and healthcare AI companies.

Nationally, healthcare AI investment has reached unprecedented levels, with $10.5 billion in VC funding in 2024 and healthcare AI spending hitting $1.4 billion in 2025. The directory includes leading firms such as Andreessen Horowitz, 7wireVentures, Rock Health, and Digital Health Venture Partners that have demonstrated sustained commitment to healthcare AI innovation. Specialized investors like RH Capital (women's health), Virtue VC (healthcare operations), and Overwater Ventures (consumer health) provide targeted options for companies with specific focus areas.

The accelerator landscape offers diverse options for healthcare AI companies at various stages, from non-dilutive NIH and NSF funding to equity-based programs like Cedars-Sinai Accelerator and Medtech Innovator. Pitch competitions including MedTech Color, MEDICA START-UP COMPETITION, and Health Tech Challengers provide visibility and prize opportunities that can accelerate company development and investor connections.

Healthcare AI entrepreneurs should approach investors strategically, matching company focus areas and development stages with appropriate investors. Initial outreach should be professional and concise, demonstrating clear understanding of the target investor's thesis and portfolio. The relationship-driven nature of healthcare investing emphasizes the importance of warm introductions where possible, with platforms like OpenVC providing pathways to investor engagement.

---

## Sources

[1] [Dallas Healthtech Investors - Ellty](https://www.ellty.com/blog/dallas-healthtech-investors) - High Reliability - Industry blog with local market data

[2] [Scientific Health Development (SHD) - Dallas-based Medtech VC](https://shdpartners.com/) - High Reliability - Primary source, firm website

[3] [Top Venture Capital Firms and Investors in Dallas - OpenVC](https://www.openvc.app/investor-lists/venture-capital-firms-investors-dallas) - High Reliability - Established investor database

[4] [AI Healthcare Capital - Healthcare Technology PE Fund](https://aihealthcarecapital.com/) - High Reliability - Primary source, firm website

[5] [Lakewood Healthcare Capital - Dallas](https://www.lakewoodhc.com/) - Medium Reliability - Firm website (under construction)

[6] [North Texas Angel Network](https://www.northtexasangels.org/) - High Reliability - Primary source, organization website

[7] [Cowtown Angels - Fort Worth](https://www.cowtownangels.org/) - High Reliability - Primary source, organization website

[8] [Angel Physicians Fund](https://www.angelphysicians.com/) - Medium Reliability - Organization website

[9] [Health Wildcatters - Dallas Healthcare Accelerator](https://www.healthwildcatters.com/) - High Reliability - Primary source, accelerator website

[10] [Healthcare AI Spending and Funding Data - Menlo Ventures/PitchBook](https://menlovc.com/perspective/2025-the-state-of-ai-in-healthcare/) - High Reliability - VC firm research with industry data

[11] [16 Best Digital Health Investors in 2025 - MedTech Founder](https://medtechfounder.com/best-digital-health-investors/) - High Reliability - Industry publication with verified investor information

[12] [Digital Health Venture Partners - Seed-stage Healthcare VC](https://dhvp.io/) - High Reliability - Primary source, firm website

[13] [15 Best Healthcare VC Firms: The 2025 Investor List - Rho](https://www.rho.co/blog/vcs-in-healthcare) - High Reliability - Industry publication with comprehensive data

[14] [HealthTech Capital - Early-stage HealthTech Investor](https://healthtechcapital.com/) - High Reliability - Primary source, organization website

[15] [7 Best Digital Health Accelerators in 2025 - MedTech Founder](https://medtechfounder.com/best-digital-health-accelerators/) - High Reliability - Industry publication with verified program details

[16] [Cedars-Sinai Accelerator Program](https://csaccelerator.com/program) - High Reliability - Primary source, accelerator website

[17] [MedTech Color Pitch Competition](https://medtechcolor.org/pitch_competition) - High Reliability - Primary source, competition website

[18] [MEDICA START-UP COMPETITION](https://www.medica-tradefair.com/en/Program/Forums/MEDICA_INNOVATION_FORUM/MEDICA_START-UP_COMPETITION_1) - High Reliability - Primary source, event website

[19] [Health Tech Challengers - Healthcare Pitch Competition](https://healthtechchallengers.com/) - High Reliability - Primary source, competition website